Test Catheter Pilot Study in Healthy Volunteers
Not Applicable
Completed
- Conditions
- Healthy
- Registration Number
- NCT00832078
- Lead Sponsor
- Coloplast A/S
- Brief Summary
The purpose of this study is to evaluate the safety of an intermittent catheter in comparison with an already existing catheter on the market. The study is a randomised, single blinded, cross-over study including 25 healthy males.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 28
Inclusion Criteria
- 18 years or older
- Male
- Signed informed consent
- Negative urine multistix
Exclusion Criteria
- Abnormalities, diseases or surgical procedures performed in the lower urinary tract
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Discomfort After each catheterisation Discomfort measured on a Visual Analog Scale (VAS) from 0 (no discomfort) to 10 (worst imaginable discomfort)
- Secondary Outcome Measures
Name Time Method Handling After each catheterisation Preference At study termination Haematuria After each catheterisation
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the safety profile of intermittent catheters in urological devices?
How does the SpeediCath device compare to standard-of-care catheters in terms of urethral trauma biomarkers?
Are there specific biomarkers that predict adverse events in male urinary catheterization trials?
What are the potential adverse events associated with SpeediCath and how are they managed clinically?
How do Coloplast's catheter innovations compare to competitor devices in healthy volunteer studies?
Trial Locations
- Locations (1)
Rigshopsitalet
🇩🇰Copenhagen, København Ø, Denmark
Rigshopsitalet🇩🇰Copenhagen, København Ø, Denmark